# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-274018
Filing Date
2020-10-22
Accepted
2020-10-22 07:23:26
Documents
128
Period of Report
2020-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 20-F | d92594d20f.htm | 20-F | 1538618
2 | EX-4.15 | d92594dex415.htm | EX-4.15 | 122795
3 | EX-4.16 | d92594dex416.htm | EX-4.16 | 96430
4 | EX-4.17 | d92594dex417.htm | EX-4.17 | 198235
5 | EX-12.1 | d92594dex121.htm | EX-12.1 | 10404
6 | EX-12.2 | d92594dex122.htm | EX-12.2 | 10723
7 | EX-13.1 | d92594dex131.htm | EX-13.1 | 6123
8 | EX-15.1 | d92594dex151.htm | EX-15.1 | 2114
| Complete submission text file | 0001193125-20-274018.txt |  | 12886921

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL INSTANCE DOCUMENT | kzia-20200630.xml | EX-101.INS | 4091177
10 | XBRL TAXONOMY EXTENSION SCHEMA | kzia-20200630.xsd | EX-101.SCH | 96295
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | kzia-20200630_cal.xml | EX-101.CAL | 44587
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | kzia-20200630_def.xml | EX-101.DEF | 310491
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | kzia-20200630_lab.xml | EX-101.LAB | 537770
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | kzia-20200630_pre.xml | EX-101.PRE | 471828

Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-29962 | Film No.: 201251671
SIC: 2834 Pharmaceutical Preparations